Oxford Medical Diagnostics Ltd (Now Avacta Plc)
Oxford Medical Diagnostics Ltd, the 39th company to spin out from Oxford since 1997. OMD was acquired by Avacta plc in 2007, OMD’s patented Cavity Enhanced Laser Spectroscopy technology, based on research by Professor Gus Hancock's group in the Chemistry Department, uses infrared absorption spectroscopy and is targeted at two major markets: industrial process monitoring and, in the longer term, clinical diagnosis through the rapid analysis of breath samples.